T/CSBME 079-2024
Quality acceptance requirements for clinical used PET/CT positron drugs in lung cancer (English Version)

Standard No.: T/CSBME 079-2024
Language: Chinese, Available in English version
Release Date: 2024
Published By: Group Standards of the People's Republic of China
Latest: T/CSBME 079-2024

Scope: This document stipulates the quality acceptance requirements for the clinical use of PET/CT positron drugs for lung cancer.

T/CSBME 079-2024 history

2024 T/CSBME 079-2024 Quality acceptance requirements for clinical used PET/CT positron drugs in lung cancer

Topics on standards and specifications

Overseas Drug Clinical Trials early lung cancer advanced lung cancer Clinical use of commonly used ototoxic drugs Positron pet

Standard and Specification

IEC TR 61948-3:2018 Nuclear medicine instrumentation - Routine tests - Part 3: Positron emission tomographs BS PD IEC/TR 61948-3:2018 Nuclear medicine instrumentation. Routine tests-Positron emission tomographs EN IEC 63077:2019 Good refurbishment practices for medical imaging equipment GSO IEC 63077:2021 Good refurbishment practices for medical imaging equipment NEMA NU 2-2012 Performance Measurements of Positron Emission Tomographs BS PD CEN ISO/TS 22756:2020 Health Informatics. Requirements for a knowledge base for clinical decision support systems to be used in medication-related processes GB 17589-2011 Specifications for quality assurance test for computed tomography X-ray scanners CLSI I/LA34-P-2010 Design and Validation of Immunoassays for Assessment of Human allergenicity of New Biotherapeutic Drugs SN-CEN ISO/TS 22756:2020 Health Informatics — Requirements for a knowledge base for clinical decision support systems to be used in medication-related processes (ISO/TS 22756:2020 CEN ISO/TS 22756:2020 Health Informatics - Requirements for a knowledge base for clinical decision support systems to be used in medication-related processes (ISO/TS 22756:2020

Copyright ©2025 All Rights Reserved